Michael F. Grunebaum, MD
- 9Articles
- 42.8KReads
- 2001–2021Active
- 27Collaborators
- 130Citations
About
Michael F. Grunebaum, MD, is affiliated with the Department of Molecular Imaging and Neuropathology at the New York State Psychiatric Institute in New York. His publications from 2001 to 2021 focus on suicide and neurology, covering topics such as the neurocognitive effects of ketamine in depressed patients with suicidal ideation, the use of big data in suicidology, and the impact of parental depression on offspring suicidal behavior. He has also studied antidepressant effects on symptom clusters in suicidal depression, omega-3 fatty acid status in major depressive disorder with anxiety, and the relationship between antidepressant prescription rates and suicide risk.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
